The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Update on pilot study on antitumor efficacy of intravenously applied synergistic combinations of diflunisal, PAS, and aspirin in patients with advanced solid tumors.
Joachim Drevs
Consultant or Advisory Role - DifluMed Pharmaceutical UG
Susanne D'Urso
No relevant relationships to disclose
Martin Dayton
No relevant relationships to disclose
Lukas Martinez
No relevant relationships to disclose
Jonas Mueller-Huebenthal
No relevant relationships to disclose
Izumi Kamijo
Employment or Leadership Position - DifluMed Pharmaceutical UG
Werner Kreutz
Employment or Leadership Position - DifluMed Pharmaceutical UG (U)